Ozel, O. Et Al. 2016. Complete response to bevacizumab plus irinotecan in patients with rapidly progressive GBM: Cases report and literature review. Journal of Oncological Sciences , no.2 , 87-94.

Ozel, O., Kurt, ., Ozdemir, ., Bayram, J., Akdeniz, H., & Koca, ., (2016). Complete response to bevacizumab plus irinotecan in patients with rapidly progressive GBM: Cases report and literature review. Journal of Oncological Sciences , no.2, 87-94.

Ozel, Oguz Et Al. "Complete response to bevacizumab plus irinotecan in patients with rapidly progressive GBM: Cases report and literature review," Journal of Oncological Sciences , no.2, 87-94, 2016

Ozel, Oguz Et Al. "Complete response to bevacizumab plus irinotecan in patients with rapidly progressive GBM: Cases report and literature review." Journal of Oncological Sciences , no.2, pp.87-94, 2016

Ozel, O. Et Al. (2016) . "Complete response to bevacizumab plus irinotecan in patients with rapidly progressive GBM: Cases report and literature review." Journal of Oncological Sciences , no.2, pp.87-94.

@article{article, author={Oguz Ozel Et Al. }, title={Complete response to bevacizumab plus irinotecan in patients with rapidly progressive GBM: Cases report and literature review}, journal={Journal of Oncological Sciences}, year=2016, pages={87-94} }